broker prediction, page-7

I was wondering what acl had done wrong this year, to fall from the $1.40's. So I trauled through their announcements:

~ Successful manufacture scale-up of Heparin thingy
~ gsk announced great data in Arixtra VTE trial
~ Successfully tookover Meditech Research
~ gsk announced great data in Arixtra ACS trial
~ HyCamp phase 2 study enrollment completed
~ Announced collaboration with Euroscreen

As you can see, the company has let us down again & again. No wonder the sp has been punished!

And all the time we are getting closer & closer to 2008 & $$$$$$$$$$$'s.

buy & hold & hold & hold